top of page
Search

[The Signaling Secret] PRP vs. PRF

  • 5 days ago
  • 2 min read

Translating Cellular Signaling into Clinical Gold Standards


While Dr. Richard Miron is back at headquarters mapping out the final details of our upcoming clinical tracks, his research footprint continues to reshape regenerative esthetics across the globe.

 

When you seek to naturally reverse signs of aging, optimize tissue rejuvenation, or treat stubborn dermal pathologies, a primary question must guide your treatment choices: What actually happens to tissue-regenerating cells at a cellular level when you introduce blood concentrates?

 

In a narrative review published in Periodontology 2000, Dr. Miron and co-author Dr. Catherine Davies dissected the exact cellular mechanisms of autologous platelet concentrates (APCs) within esthetic medicine. The clinical data exposes sharp, critical variances between standard Platelet-Rich Plasma (PRP) and liquid Platelet-Rich Fibrin (PRF):

  • 350% Migration Jump: In controlled assays, liquid-PRF accelerated skin fibroblast migration by nearly 350% compared to baseline controls. Traditional PRP, limited by chemical anticoagulants, capped out significantly lower at a 200% increase.

  • Advanced Extracellular Expression: While both modalities elevate local growth factor levels, liquid-PRF triggers significantly higher mRNA expression of Transforming Growth Factor-beta (TGF-β), Type 1 Collagen (COL1), and fibronectin.

  • True Sustained Release: Because PRF utilizes a completely additive-free formulation, it completely avoids the immediate "burst release" seen in anticoagulant-dependent protocols[cite: 1, 2]. Instead, it creates a 3D fibrin mesh that sustains a steady, gradual release of growth factors for 7 to 14+ days.

Fibroblast Migration Assay (Wang et al. 2019 / Davies & Miron 2024): (A) Human skin fibroblasts cultured with fluid-PRF vs. PRP after 24h. (B) Quantification showing liquid-PRF driving cell migration up to ~350% compared to control and standard PRP (~200%).
Fibroblast Migration Assay (Wang et al. 2019 / Davies & Miron 2024): (A) Human skin fibroblasts cultured with fluid-PRF vs. PRP after 24h. (B) Quantification showing liquid-PRF driving cell migration up to ~350% compared to control and standard PRP (~200%).

Real-World Efficacy: Acne Scars & Volume Loss


Transitioning these cell-level findings into clinical practice yields striking data:

  • Acne Scar Resolution: When evaluating combination therapies for atrophic acne scars, a split-face clinical trial highlighted by the authors revealed that microneedling with PRF yielded a 53.3% rate of "excellent" clinical outcomes, more than doubling the 20% success rate achieved by microneedling with PRP.

  • Extended Volume Replacement (Alb-PRF / Bio-Filler): By passing platelet-poor plasma through a precise thermal denaturation process (Bio-Heat) and mixing it back with native liquid PRF, clinicians create a 100% natural, high-density gel. This advanced biomaterial provides a steady 4-to-6-month volumizing effect while actively building native collagen matrix over time, overcoming the rapid resorption limitations of regular liquid concentrates.



Miron Message | Bringing the global standard of regenerative medicine into daily practice


Dr. Richard Miron

Comments

bottom of page